Stock Name: Biosensors
Company Name: BIOSENSORS INT'L GROUP, LTD.
Research House: DBS Vickers
“Apart from Japan, we believe Biosensors is making progress in other operational areas through market share gains or penetration, flanked by new product launches,” said DBS in a report
Company Name: BIOSENSORS INT'L GROUP, LTD.
Research House: DBS Vickers
DBS Vickers has upgraded Singapore’s medical technology firm Biosensors International (BIOS.SI) to buy from hold and raised its target price to $1.35 from $1.13.
DBS raised its price target as it expects the firm to receive approval for one of its stents, the BioMatrix, from Japan in the next 12 months, which would be a catalyst for its share price.
DBS raised its price target as it expects the firm to receive approval for one of its stents, the BioMatrix, from Japan in the next 12 months, which would be a catalyst for its share price.
“Apart from Japan, we believe Biosensors is making progress in other operational areas through market share gains or penetration, flanked by new product launches,” said DBS in a report
At 10:55 a.m., shares of Biosensors were 1.7% higher at $1.17. They have gained 4.5% since the start of the year.
No comments:
Post a Comment